ZH

RU

ES

New drug packaging

New drug packaging, Total:500 items.

In the international standard classification, New drug packaging involves: Packaging and distribution of goods in general, Equipment for children, Aids for disabled or handicapped persons, Pharmaceutics, Quality, Packaging machinery, Packaging materials and accessories, Aircraft and space vehicles in general, Paper products, Cases. Boxes. Crates, Bottles. Pots. Jars, Laboratory medicine, Products of non-ferrous metals, Sterilization and disinfection, Protection against dangerous goods, Freight distribution of goods, Characteristics and design of machines, apparatus, equipment, Equipment for the chemical industry, General methods of tests and analysis for food products, Domestic safety, Standardization. General rules, Food products in general, Microbiology, Raw materials for rubber and plastics, Rubber and plastics products, Materials and articles in contact with foodstuffs, Sacks. Bags, Medical sciences and health care facilities in general, Applications of information technology, Postal services.


U.S. Military Regulations and Norms, New drug packaging

HU-MSZT, New drug packaging

British Standards Institution (BSI), New drug packaging

  • BS EN ISO 28862:2023 Packaging. Child-resistant packaging. Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • BS EN 862:2016 Tracked Changes. Packaging. Child-resistant packaging. Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • BS EN ISO 17351:2014 Packaging. Braille on packaging for medicinal products
  • BS EN 15823:2010 Packaging - Braille on packaging for medicinal products
  • BS EN 16679:2014 Packaging. Tamper verification features for medicinal product packaging
  • BS EN ISO 21976:2020 Packaging. Tamper verification features for medicinal product packaging
  • BS EN ISO 14375:2023 Child-resistant non-reclosable packaging for pharmaceutical products. Requirements and testing
  • BS EN 14375:2016 Tracked Changes. Child-resistant non-reclosable packaging for pharmaceutical products. Requirements and testing
  • 18/30329288 DC BS EN ISO 16106. Transport packages for dangerous goods. Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings. Guidelines for the application of ISO 9001
  • BS 8404:2001 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for pharmaceutical products
  • BS ISO 28862:2018 Packaging. Child-resistant packaging. Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • BS EN 862:2005 Packaging — Childresistant packaging — Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • BS EN 862:2006 Packaging. Child resistant packaging. Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • BS PD CEN/TS 17523:2020 Postal services. Packaging for boxable items. Characteristics for packaging of small and light weight items to be delivered into the consumer's letterbox
  • BS PD CEN/TS 54-14:2018 Postal services. Packaging for boxable items. Characteristics for packaging of small and light weight items to be delivered into the consumer's letterbox
  • BS EN ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001
  • BS EN ISO 16106:2020 Tracked Changes. Transport packages for dangerous goods. Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings. Guidelines for the application of ISO 9001
  • BS EN 1086:1996 Sacks for the transport of food aid - Recommendations on the selection of type of sack and the liner in relation to the product to be packed
  • BS 7236:1989 Code of practice for non-reclosable packaging for solid dose units of medicinal products
  • BS DD 264:2007 Packaging - Braille and other formats for medicinal products

ES-UNE, New drug packaging

  • UNE-EN 862:2016 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • UNE-EN ISO 21976:2021 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)
  • UNE-EN 14375:2016 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing

German Institute for Standardization, New drug packaging

  • DIN EN 862:2016-09 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products; German version EN 862:2016 / Note: To be replaced by DIN EN ISO 28862 (2022-12).
  • DIN EN ISO 28862:2022-12 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products (ISO 28862:2018); German and English version prEN ISO 28862:2022 / Note: Date of issue 2022-11-04*Intended as replac...
  • DIN EN ISO 17351:2014-10 Packaging - Braille on packaging for medicinal products (ISO 17351:2013); German version EN ISO 17351:2014
  • DIN EN ISO 14375:2023-07 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing (ISO 14375:2018); German version EN ISO 14375:2023
  • DIN EN 14375 Berichtigung 1:2006 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing; German version EN 14375:2003, Corrigenda to DIN EN 14375:2004-02; German version EN 14375:2003/AC:2006
  • DIN EN ISO 21976:2020-12 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018); German version EN ISO 21976:2020
  • DIN EN 15823:2010 Packaging - Braille on packaging for medicinal products; German version EN 15823:2010
  • DIN EN ISO 16106:2020 Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2020)
  • DIN EN ISO 17351:2014 Packaging - Braille on packaging for medicinal products (ISO 17351:2013); German version EN ISO 17351:2014
  • DIN EN 16679:2015 Packaging - Tamper verification features for medicinal product packaging; German version EN 16679:2014
  • DIN EN ISO 21898:2023-06 Packaging - Flexible intermediate bulk containers (FIBCs) for non-dangerous goods (ISO/DIS 21898:2023); German and English version prEN ISO 21898:2023 / Note: Date of issue 2023-05-05*Intended as replacement for DIN EN ISO 21898 (2005-12).
  • DIN EN ISO 21976:2020 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018); German version EN ISO 21976:2020
  • DIN EN ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2006); English version of DIN EN ISO 16106:2006-06

Underwriters Laboratories (UL), New drug packaging

  • UL 1442-1999 UL Standard for Safety Repackaged Products Second Edition

Association Francaise de Normalisation, New drug packaging

  • NF H00-202*NF EN 862:2016 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • NF EN ISO 17351:2014 Emballage - Braille sur les emballages destinés aux médicaments
  • NF H00-016:2010 Packaging - Braille on packaging for medicinal products.
  • NF H00-016*NF EN ISO 17351:2014 Packaging - Braille on packaging for medicinal products
  • NF EN ISO 14375:2023 Emballages non refermables à l'épreuve des enfants pour produits pharmaceutiques - Exigences et essais
  • NF EN ISO 21976:2020 Emballage - Témoins d'effraction pour emballages de médicaments
  • NF EN 14375:2016 Emballages à l'épreuve des enfants, non refermables pour produits pharmaceutiques - Exigences et essais
  • NF H60-251:2015 Packaging - Tamper verification features for medicinal product packaging
  • NF H60-251*NF EN ISO 21976:2020 Packaging - Tamper verification features for medicinal product packaging
  • NF H00-101*NF EN ISO 16106:2020 Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001
  • NF EN ISO 28862:2023 Emballages - Emballage à l'épreuve des enfants - Exigences et méthodes d'essai pour emballages non refermables pour les produits non pharmaceutiques
  • NF EN 862:2016 Emballages - Emballage à l'épreuve des enfants - Exigences et méthodes d'essai pour emballages non refermables pour les produits non pharmaceutiques
  • NF H00-101:2007 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001.
  • NF H00-202:1997 Packaging. Child-resistant packaging. Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products.
  • FD H00-019*FD CEN/TR 15753:2008 Packaging - Package leaflets for medicinal products - Braille and other formats for visually impaired people
  • NF H00-202:2006 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products.
  • NF H00-204:2004 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing.

Danish Standards Foundation, New drug packaging

  • DS/EN 862:2006 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • DS/EN 15823:2010 Packaging - Braille on packaging for medicinal products
  • DS/ISO 17351:2013 Packaging - Braille on packaging for medicinal products
  • DS/ISO 21976:2020 Packaging – Tamper verification features for medicinal product packaging
  • DS/EN ISO 21976:2020 Packaging – Tamper verification features for medicinal product packaging (ISO 21976:2018)
  • DS/CEN/TR 15753:2008 Packaging - Package leaflets for medicinal products - Braille and other formats for visually impaired people
  • DS/ISO 16883:2007 Packaging - Transport packages for dangerous goods - Test methods for large packagings
  • DS/EN ISO 13274:2013 Packaging - Transport packaging for dangerous goods - Plastics compatibility testing for packaging and IBCs
  • DS/EN ISO 21898:2005 Packaging - Flexible intermediate bulk containers (FIBCs) for non-dangerous goods

Lithuanian Standards Office , New drug packaging

  • LST EN 862-2006 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • LST EN 15823-2010 Packaging - Braille on packaging for medicinal products
  • LST EN ISO 17351:2014 Packaging - Braille on packaging for medicinal products (ISO 17351:2013)
  • LST EN ISO 21976:2020 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)
  • LST EN ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2006)
  • LST EN ISO 16467:2004 Packaging - Transport packaging for dangerous goods - Test methods for IBCs (ISO 16467:2003)

International Organization for Standardization (ISO), New drug packaging

  • ISO 17351:2013 Packaging - Braille on packaging for medicinal products
  • ISO 21976:2018 Packaging — Tamper verification features for medicinal product packaging
  • ISO 28862:2018 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001
  • ISO 11239:2012 Health informatics - Identification of medicinal products - Data elements and structures for the unique identification and exchange of regulated information on pharmaceutical dose forms, units of presentation, routes of administration and packaging
  • ISO 14375:2018 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing
  • ISO/DIS 21898 Packaging — Flexible intermediate bulk containers (FIBCs) for non-dangerous goods

国家市场监督管理总局、中国国家标准化管理委员会, New drug packaging

European Committee for Standardization (CEN), New drug packaging

  • EN 15823:2010 Packaging - Braille on packaging for medicinal products
  • EN 16679:2014 Packaging - Tamper verification features for medicinal product packaging
  • EN ISO 17351:2014 Packaging - Braille on packaging for medicinal products
  • EN ISO 21976:2020 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)
  • EN ISO 13127:2012 Packaging - Child resistant packaging - Mechanical test methods for reclosable child resistant packaging systems
  • EN ISO 13127:2012/AC:2012 Packaging - Child resistant packaging - Mechanical test methods for reclosable child resistant packaging systems - Technical Corrigendum 1 (ISO 13127:2012/Cor 1:2012)
  • EN ISO 28862:2023 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products (ISO 28862:2018)
  • EN 862:2005 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for nonpharmaceutical products
  • EN 862:1997 Packaging - Child-Resistant Packaging - Requirements and Testing Procedures for Non-Reclosable Packages for Non-Pharmaceutical Products
  • EN 862:2001 Packaging - Child-Resistant Packaging - Requirements and Testing Procedures for Non-Reclosable Packages for Non-Pharmaceutical Products
  • PD CEN/TR 15753:2008 Packaging - Package leaflets for medicinal products - Braille and other formats for visually impaired people
  • EN 862:2016 Packaging - Child-resistant packaging - Requirements and testing procedures for non-reclosable packages for nonpharmaceutical products
  • EN ISO 16106:2020 Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2020)
  • EN ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2006)
  • EN ISO 14375:2023 Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing (ISO 14375:2018)
  • prEN ISO 21898 rev Packaging - Flexible intermediate bulk containers (FIBCs) for non-dangerous goods

Standard Association of Australia (SAA), New drug packaging

Professional Standard - Machinery, New drug packaging

General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China, New drug packaging

  • GB 12255-1990 Aluminum foils packaging for medicine
  • GB/T 15692.7-1995 Terms of pharmaceutical machinery--Pharmaceutical packaging machinery
  • GB 9687-1988 Hygienic standard for polyethylene products used as food containers and tablewares
  • GB 9688-1988 Hygienic standard for polypropyrene products used as food containers and tablewares
  • GB/T 42089-2022 Child-resistant packaging—Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products
  • GB/T 38461-2020 Blow mould for PET bottle in food field
  • GB 16332-1996 Hygienic standard of products of nylon for food packaging material
  • GB 9681-1988 Hygienic standard of products of polyvinyl chloride for food packaging
  • GB 9689-1988 Hygienic standard for polystyrene products used as food containers and tablewares
  • GB 9690-1988 Hygienic standard for melamine products used as food containers and tablewares

Professional Standard - Pharmaceutical Packaging, New drug packaging

  • YBB 0015-2002 yaoyongbaozhuangyonglvbo Aluminium foils packaging for medicine
  • YBB 0015(02)-2002 Aluminum foil for pharmaceutical packaging (trial implementation)
  • YBB 0013-2002 Yaopinbaozhuangyong Fuhemo、Dai Tongze General Rule for Laminated Films and Pouches for Pharmaceutical Packaging
  • YBB 0021-2004 General Rules for Foil Laminated Closure Liners for Pharmaceutical Packaging
  • YBB 0013(02)-2002 General Rules for Composite Films and Bags for Pharmaceutical Packaging (Trial)
  • YBB 0014-2002 Yaopinbaozhuangcailiao yu yaowu xiangrongxingshiyan zhidao yuanze Guidelines of evaluating compatibility between pharmaceutical packaging and pharmaceuticals
  • YBB 0014(02)-2002 Guidelines for Compatibility Testing of Drug Packaging Materials and Drugs (Trial)
  • YBB 0017-2002 Juzhi/lubo/JvyixiYaopinbaozhuangyong Fuhemo、Dai Laminated Films and Pouches (PET/Al/PE) for Pharmaceutical Packaging
  • YBB 0020-2004 Laminated Films and Pouches (PT/Al/PE) for Pharmaceutical Packaging
  • YBB 0018-2002 Juzhi/DimiduJuyixiYaopinbaozhuangyong Fuhemo、Dai Laminated Films and Pouches (PET/LDPE) for Pharmaceutical Packaging
  • YBB 0017(02)-2002 Composite film and bag for polyester/aluminum/polyethylene pharmaceutical packaging (trial implementation)
  • YBB 0041-2004 Test methods for clean room to produce pharmaceutical packaging materials
  • YBB 0018(02)-2002 Polyester/low-density polyethylene composite film and bag for pharmaceutical packaging (trial implementation)
  • YBB 00412004-2015 Test methods for clean rooms (areas) of pharmaceutical packaging material production plants

工业和信息化部/国家能源局, New drug packaging

Korean Agency for Technology and Standards (KATS), New drug packaging

  • KS T 5013-2022 Packaging — Tamper verification features for medicinal product packaging in good distribution practice principle
  • KS T 5012-2020 Packaging — Complete, filled transport packages —Requirements of passive type packaging for temperature controlled transport of pharmaceuticals
  • KS T ISO 16883:2013 Packaging ― Transport packages for dangerous goods ― Test methods for large packagings
  • KS T ISO 16106:2013 Packaging ― Transport packages for dangerous goods-Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings ― Guidelines for the application of KS A ISO 9001
  • KS T ISO 16106:2008 Packaging-Transport packages for dangerous goods-Dangerous goods packagings, intermediate bulk containers(IBCs) and large packagings-Guidelines for the application of KS A ISO 9001

AENOR, New drug packaging

  • UNE-EN ISO 17351:2014 Packaging - Braille on packaging for medicinal products (ISO 17351:2013)
  • UNE-EN 16679:2015 Packaging - Tamper verification features for medicinal product packaging
  • UNE 49195:2011 Guide of packaging for fresh products of extractive fishing.
  • UNE-EN ISO 16106:2006 Packaging - Transport packages for dangerous goods - Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings - Guidelines for the application of ISO 9001 (ISO 16106:2006)
  • UNE-CEN/TR 15753:2009 IN Packaging - Package leaflets for medicinal products - Braille and other formats for visually impaired people
  • UNE-EN ISO 13274:2014 Packaging - Transport packaging for dangerous goods - Plastics compatibility testing for packaging and IBCs (ISO 13274:2013)

IT-UNI, New drug packaging

Military Standards (MIL-STD), New drug packaging

Group Standards of the People's Republic of China, New drug packaging

  • T/ZSM 0020-2023 Paperboard folding carton for pharmaceutical package
  • T/CASME 614-2023 Specification for production of new corrugated paper packaging boxes
  • T/QGCML 974-2023 New Cosmetic Processing and Grinding Device
  • T/CAQI 159-2020 Sampling and Real-time RT-PCR assay for detection of SARS-CoV-2 in food and food packaging surface
  • T/SMA 0027-2022 Guidelines for Drug Packaging Reduction—Tablet and Capsule
  • T/HTCMA 00002-2021 Standard for biodegradable plastic packaging bags for drug dispensing
  • T/BPMA 0004-2020 The technical guide of coronavirus disease 2019 sample collection, packaging, transportation and testing

ET-QSAE, New drug packaging

RO-ASRO, New drug packaging

  • STAS 2413-1987 Glass paekagcs C.LASS BOTTI.KS FOH CHEMICAL ANI) l'IIAMMACEC- TICAL I'iiODrCTS
  • STAS 5598-1987 PRODUCTS OF OSIER WILLOW WATTLES Baskets for pharmaceutical products

CZ-CSN, New drug packaging

Professional Standard - Medicine, New drug packaging

  • YY 0236-1996 Composite Films for Pharmaceutical Packaging (General Rules)

RU-GOST R, New drug packaging

  • GOST 34036-2016 Glass packaging for medicines. General specifications
  • GOST R 55274-2012 Packaging. Transport packages for dangerous goods. Dangerous goods packagings, intermediate bulk containers (IBCs) and large packagings. Guidelines for the application of GOST R ISO 9001-2008
  • GOST 25250-1988 PVC film for production of food and medicine package. Specifications

Tianjin Provincial Standard of the People's Republic of China, New drug packaging

  • DB12/T 1165-2022 Articles and article packaging Novel coronavirus sample collection, storage, and transportation technical specifications

Inner Mongolia Provincial Standard of the People's Republic of China, New drug packaging

  • DB15/T 1174-2017 Pharmaceutical logistics refrigerated drug transport packaging requirements
  • DB15/T 1484-2018 Packaging requirements for refrigerated and frozen pharmaceutical logistics

Shanghai Provincial Standard of the People's Republic of China, New drug packaging

  • DB31/T 1434-2023 Technical specifications for novel coronavirus disinfection of imported cold chain food outer packaging

US-HHS, New drug packaging

US-FCR, New drug packaging

CH-SNV, New drug packaging

  • SN EN ISO 21976:2021 Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)

PL-PKN, New drug packaging

CU-NC, New drug packaging

  • NC 97-67-1985 Packaging. Glass Containers for Drugs. General Quality Specifications

US-CFR-file, New drug packaging

  • CFR 21-526.1590-2014 Food and drugs. Part526:Intramammary dosage form new animal drugs. Section526.1590:Novobiocin infusion.
  • CFR 21-522.1484-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1484:Neomycin.
  • CFR 21-522.1698-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1698:Pentazocine.
  • CFR 21-520.1604-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1604:Oclacitinib.
  • CFR 21-522.1503-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1503:Neostigmine.
  • CFR 21-524.981c-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.981c:Fluocinolone and neomycin cream.
  • CFR 21-520.600-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.600:Dichlorvos.
  • CFR 21-524.1484j-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484j:Neomycin and prednisolone ophthalmic ointment.
  • CFR 21-520.1780-2014 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1780:Pimobendan.
  • CFR 21-520.309-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.309:Carprofen.
  • CFR 21-520.1367-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1367:Meloxicam.
  • CFR 21-520.1408-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1408:Methylprednisolone tablets.
  • CFR 21-520.1900-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1900:Primidone tablets.
  • CFR 21-520.812-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.812:Enrofloxacin.
  • CFR 21-520.2345d-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.2345d:Tetracycline powder.
  • CFR 21-524.1484k-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484k:Prednisolone and neomycin suspension.
  • CFR 21-520.2075-2014 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.2075:Robenacoxib.
  • CFR 21-520.390a-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.390a:Chloramphenicol tablets.
  • CFR 21-524.2098-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.2098:Selamectin.
  • CFR 21-520.622b-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.622b:Diethylcarbamazine citrate syrup.
  • CFR 21-520.763a-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.763a:Dithiazanine iodide tablets.
  • CFR 21-520.763b-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.763b:Dithiazanine iodide powder.
  • CFR 21-520.2471-2014 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.2471:Tilmicosin.
  • CFR 21-520.38b-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.38b:Albendazole paste.
  • CFR 21-526.1810-2014 Food and drugs. Part526:Intramammary dosage form new animal drugs. Section526.1810:Pirlimycin.
  • CFR 21-526.313-2014 Food and drugs. Part526:Intramammary dosage form new animal drugs. Section526.313:Ceftiofur.
  • CFR 21-524.1484i-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484i:Neomycin and hydrocortisone ointment.
  • CFR 21-524.154-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.154:Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
  • CFR 21-524.1240-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1240:Levamisole.
  • CFR 21-520.955-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.955:Florfenicol.
  • CFR 21-520.38a-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.38a:Albendazole suspension.
  • CFR 21-524.402-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.402:Chlorhexidine.
  • CFR 21-524.450-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.450:Clotrimazole.
  • CFR 21-524.900-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.900:Famphur.
  • CFR 21-524.916-2013 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.916:Fentanyl.
  • CFR 21-524.920-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.920:Fenthion.
  • CFR 21-529.1030-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1030:Formalin.
  • CFR 21-529.40-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.40:Albuterol.
  • CFR 21-524.1484e-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484e:Neomycin and polymyxin B ophthalmic solution.
  • CFR 21-524.1484g-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484g:Neomycin, thiabendazole, and dexamethasone solution.
  • CFR 21-524.1484c-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484c:Neomycin, isoflupredone, and tetracaine ointment.
  • CFR 21-520.1195-2014 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.1195:Ivermectin liquid.
  • CFR 21-520.443-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.443:Chlortetracycline tablets and boluses.
  • CFR 21-520.622a-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.622a:Diethylcarbamazine citrate tablets.
  • CFR 21-522.1962-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1962:Promazine.
  • CFR 21-522.1010-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1010:Furosemide.
  • CFR 21-522.1020-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1020:Gelatin.
  • CFR 21-524.1465-2013 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1465:Mupirocin.
  • CFR 21-524.1465-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1465:Mupirocin.
  • CFR 21-524.463-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.463:Copper naphthenate.
  • CFR 21-524.770-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.770:Doramectin.
  • CFR 21-529.1115-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1115:Halothane.
  • CFR 21-529.1150-2013 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1150:Hydrogen peroxide.
  • CFR 21-529.1660-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1660:Oxytetracycline.
  • CFR 21-529.778-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.778:Doxycycline.
  • CFR 21-524.1484d-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484d:Neomycin, hydrocortisone, and tetracaine otic ointment.
  • CFR 21-524.1484f-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1484f:Neomycin, prednisolone, and tetracaine otic suspension.
  • CFR 21-522.90-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.90:Ampicillin injectable dosage forms.
  • CFR 21-522.1452-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1452:Nalorphine.
  • CFR 21-522.2150-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2150:Stanozolol.
  • CFR 21-522.1289-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1289:Lufenuron.
  • CFR 21-522.390-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.390:Chloramphenicol.
  • CFR 21-522.1410-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1410:Methylprednisolone.
  • CFR 21-522.1465-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1465:Naltrexone.
  • CFR 21-522.1610-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1610:Oleate sodium.
  • CFR 21-524.2350-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.2350:Tolnaftate cream.
  • CFR 21-522.820-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.820:Erythromycin.
  • CFR 21-522.82-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.82:Aminopropazine.
  • CFR 21-522.883-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.883:Etorphine.
  • CFR 21-522.2005-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2005:Propofol.
  • CFR 21-522.204-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.204:Boldenone.
  • CFR 21-524.1005-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1005:Furazolidone powder.
  • CFR 21-522.1066-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1066:Glycopyrrolate.
  • CFR 21-522.234-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.234:Butamisole.
  • CFR 21-522.1182-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1182:Iron injection.
  • CFR 21-522.1204-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1204:Kanamycin.
  • CFR 21-522.2615-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2615:Tripelennamine.
  • CFR 21-522.1242-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1242:Levamisole.
  • CFR 21-522.2670-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2670:Yohimbine.
  • CFR 21-522.304-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.304:Carprofen.
  • CFR 21-524.390-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.390:Chloramphenicol ophthalmic ointment.
  • CFR 21-524.660-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.660:Dimethyl sulfoxide.
  • CFR 21-524.86-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.86:Amitraz.
  • CFR 21-524.981b-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.981b:Fluocinolone solution.
  • CFR 21-526.1696d-2014 Food and drugs. Part526:Intramammary dosage form new animal drugs. Section526.1696d:Penicillin G procaine novobiocin for intramammary infusion.
  • CFR 21-520.28-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.28:Acetazolamide sodium soluble powder.
  • CFR 21-522.144-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.144:Arsenamide.
  • CFR 21-524.1200a-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1200a:Kanamycin ophthalmic ointment.
  • CFR 21-522.311-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.311:Cefovecin.
  • CFR 21-522.1260-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1260:Lincomycin.
  • CFR 21-522.1315-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1315:Maropitant.
  • CFR 21-522.1335-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1335:Medetomidine.
  • CFR 21-524.1580a-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1580a:Nitrofurazone ointment.
  • CFR 21-522.1380-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1380:Methocarbamol.
  • CFR 21-522.522-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.522:Danofloxacin.
  • CFR 21-522.533-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.533:Deslorelin.
  • CFR 21-522.536-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.536:Detomidine.
  • CFR 21-522.161-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.161:Betamethasone.
  • CFR 21-522.62-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.62:Aminopentamide.
  • CFR 21-522.770-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.770:Doramectin.
  • CFR 21-522.1704-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1704:Pentobarbital.
  • CFR 21-522.863-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.863:Ethylisobutrazine.
  • CFR 21-522.88-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.88:Amoxicillin.
  • CFR 21-522.2002-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2002:Propiopromazine.
  • CFR 21-522.914-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.914:Fenprostalene.
  • CFR 21-522.955-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.955:Florfenicol.
  • CFR 21-522.2012-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2012:Prostalene.
  • CFR 21-522.2063-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2063:Pyrilamine.
  • CFR 21-522.2076-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2076:Romifidine.
  • CFR 21-522.970-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.970:Flunixin.
  • CFR 21-522.995-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.995:Fluprostenol.
  • CFR 21-522.23-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.23:Acepromazine.
  • CFR 21-522.2340-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2340:Sulfomyxin.
  • CFR 21-522.2424-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2424:Thiamylal.
  • CFR 21-522.1125-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1125:Hemoglobin glutamer-200 (bovine).
  • CFR 21-522.2474-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2474:Tolazoline.
  • CFR 21-522.2582-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2582:Triflupromazine.
  • CFR 21-522.2640-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2640:Tylosin.
  • CFR 21-522.1225-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1225:Ketoprofen.
  • CFR 21-522.2662-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2662:Xylazine.
  • CFR 21-522.300-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.300:Carfentanil.
  • CFR 21-524.575-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.575:Cyclosporine ophthalmic ointment.
  • CFR 21-529.2464-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.2464:Ticarcillin.
  • CFR 21-529.56-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.56:Amikacin.
  • CFR 21-522.2220-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2220:Sulfadimethoxine.
  • CFR 21-522.2240-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2240:Sulfaethoxypyridazine.
  • CFR 21-524.1200b-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1200b:Kanamycin ophthalmic solution.
  • CFR 21-522.313c-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.313c:Ceftiofur sodium.
  • CFR 21-522.460-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.460:Cloprostenol.
  • CFR 21-524.1580c-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1580c:Nitrofurazone and butacaine ointment.
  • CFR 21-522.535-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.535:Desoxycorticosterone.
  • CFR 21-522.542-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.542:Dexamethasone suspension.
  • CFR 21-524.1982-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1982:Proparacaine ophthalmic solution.
  • CFR 21-522.1680-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1680:Oxytocin.
  • CFR 21-522.784-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.784:Doxylamine.
  • CFR 21-520.763c-2013 Food and drugs. Part520:Oral dosage form new animal drugs. Section520.763c:Dithiazanine iodide and piperazine citrate suspension.
  • CFR 21-522.1720-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1720:Phenylbutazone.
  • CFR 21-522.84-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.84:Beta-aminopropionitrile.
  • CFR 21-522.1862-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1862:Pralidoxime powder for injection.
  • CFR 21-522.960a-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.960a:Flumethasone suspension.
  • CFR 21-522.960b-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.960b:Flumethasone acetate solution.
  • CFR 21-522.960c-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.960c:Flumethasone solution.
  • CFR 21-524.1044e-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1044e:Gentamicin spray.
  • CFR 21-522.2473-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2473:Tiludronate.
  • CFR 21-522.1145-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1145:Hyaluronate.
  • CFR 21-522.1150-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1150:Hydrochlorothiazide.
  • CFR 21-522.1185-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1185:Isoflupredone.
  • CFR 21-529.1940-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1940:Progesterone intravaginal inserts.
  • CFR 21-524.1600b-2014 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1600b:Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
  • CFR 21-524.1580b-2013 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1580b:Nitrofurazone soluble powder.
  • CFR 21-522.1372-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1372:Mepivacaine.
  • CFR 21-522.1468-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1468:Naproxen for injection.
  • CFR 21-522.1620-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1620:Orgotein for injection.
  • CFR 21-522.56-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.56:Amikacin.
  • CFR 21-522.723-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.723:Diprenorphine.
  • CFR 21-522.1881-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1881:Prednisolone acetate.
  • CFR 21-522.90c-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.90c:Ampicillin sodium.
  • CFR 21-522.1940-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1940:Progesterone and estradiol benzoate.
  • CFR 21-522.956-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.956:Florfenicol and flunixin.
  • CFR 21-522.2100-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.2100:Selenium and vitamin E.
  • CFR 21-524.1146-2013 Food and drugs. Part524:Ophthalmic and topical dosage form new animal drugs. Section524.1146:Imidacloprid and moxidectin.
  • CFR 21-522.1156-2014 Food and drugs. Part522:Implantation or injectable dosage form new animal drugs. Section522.1156:Imidocarb solution.
  • CFR 21-529.1044a-2014 Food and drugs. Part529:Certain other dosage form new animal drugs. Section529.1044a:Gentamicin solution for infusion.

Hebei Provincial Standard of the People's Republic of China, New drug packaging

Military Standard of the People's Republic of China-General Armament Department, New drug packaging

  • GJB 4403A-2018 Conventional weapons and ammunition packaging finalization test procedures
  • GJB 4403-2002 Conventional weapons and ammunition packaging finalization test procedures

KR-KS, New drug packaging

  • KS T ISO 16883-2013 Packaging ― Transport packages for dangerous goods ― Test methods for large packagings

Guangdong Provincial Standard of the People's Republic of China, New drug packaging

  • DB4403/T 327-2023 Specifications for the detection and sampling of new coronaviruses in imported cold chain food and packaging ports

未注明发布机构, New drug packaging

  • BS EN ISO 21898:2005(2006) Packaging — Flexible intermediate bulk containers (FIBCs) for non - dangerous goods
  • BS 1679-1:1976(1999) Specification for Containers for pharmaceutical dispensing — Part 1 : Paperboard containers for strip and blister packs

PT-IPQ, New drug packaging

  • NP EN 862-2000 Packaging Child-resistant packaging Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products

AT-ON, New drug packaging

  • ONR CEN/TS 17523-2020 Postal services - Packaging for boxable items - Characteristics for packaging of small and light weight items to be delivered into the consumer's letterbox (CEN/TS 17523:2020)

CO-ICONTEC, New drug packaging

Professional Standard - Chemical Industry, New drug packaging

Professional Standard - Commodity Inspection, New drug packaging

  • SN/T 1891.1-2007 Hygienic standard for import and export microwave food containers and packaging materials.Part1: Products of polypropylene
  • SN/T 1891.3-2007 Hygienic standard for import and export microwave food containers and packaging materials.Part3: Products of polyethylene




Copyright ©2007-2023 ANTPEDIA, All Rights Reserved